
For expanded information about Echosens market-leading technologies:
Market Leading NonInvasive NAFLD-NASH Diagnostics
Echosens, the providers of the FibroScan® family of products, is the market-leading provider of non-invasive tools for liver health assessment at the point of care. Echosens technologies include the VCTE™, CAP™ and FAST™ Score diagnostic tools providing comprehensive capabilities to identify, risk stratify and monitor NAFLD-NASH. As the inventors of liver elastography, Echosens technologies are validated in over 2500 peer-review publications and worldwide clinical practice guidelines.
A FibroScan Model For Every Care Level
The FibroScan® device is available in a variety of models to meet the needs of all levels of care. The FibroScan® Mini is fully portable, battery-powered system to meet the needs of mobile diagnostic services while the FibroScan® Compact combines portability with a high-volume testing user interface. The recently introduced FibroScan Expert provides the hepatology specialty center with expanded capabilities to include spleen stiffness assessment as a marker of portal hypertension.